Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
3.140
0.00 (0.00%)
Aug 14, 2025, 11:30 AM - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $97.30 million as of August 14, 2025. Its market cap has decreased by -43.72% in one year.
Market Cap
97.30M
Enterprise Value
49.09M
1-Year Change
-43.72%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $97.30M, a decrease of -72.68%. That is a compound annual growth rate of -62.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 100.70M | 17.23% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |